Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antidepressants To Add Class Labeling On Pregnancy & Serotonin Syndrome

Executive Summary

Antidepressants remain at the forefront of FDA's safety focus with a pair of public health advisories on use during pregnancy and on concomitant use with triptans

You may also be interested in...



Impact of Antidepressant Black Box Juggled By Advisory Committee, FDA

The addition of new, positive data on adult suicidality to antidepressant labeling could be an opportunity to offset the negative impact the "black box" warning on pediatric suicidality has had on antidepressant use, according to members of FDA's Psychopharmacologic Drugs Advisory Committee

Impact of Antidepressant Black Box Juggled By Advisory Committee, FDA

The addition of new, positive data on adult suicidality to antidepressant labeling could be an opportunity to offset the negative impact the "black box" warning on pediatric suicidality has had on antidepressant use, according to members of FDA's Psychopharmacologic Drugs Advisory Committee

Antidepressant “Black Box” Presents Barrier To DTC Advertising

FDA's proposed "black box" warning for all antidepressants would likely mean an end to television ads for the products

UsernamePublicRestriction

Register

PS047400

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel